acemetacin has been researched along with Rheumatic Diseases in 5 studies
acemetacin : A carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation. Its activity is due to both acemetacin and its major metabolite, indometacin.
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this post hoc analysis of a prospective, one-arm clinical study of a short-term treatment with acemetacin, a total of 406 patients with pain because of various musculoskeletal diseases with or without joint inflammation was evaluated for the influence of body mass index (BMI) on the reduction of pain at rest, pain at movement and for mobility restriction between visits one and three (primary outcome parameters)." | 9.12 | Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases. ( Dejaco, C; Duftner, C; Schirmer, M, 2007) |
| "An open, multi-centre trial was carried out to assess the efficacy and tolerance of acemetacin in the treatment of patients suffering from various rheumatic diseases." | 9.05 | Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial. ( Rechziegler, H; Zündorf, P, 1985) |
| " In this post hoc analysis of a prospective, one-arm clinical study of a short-term treatment with acemetacin, a total of 406 patients with pain because of various musculoskeletal diseases with or without joint inflammation was evaluated for the influence of body mass index (BMI) on the reduction of pain at rest, pain at movement and for mobility restriction between visits one and three (primary outcome parameters)." | 5.12 | Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases. ( Dejaco, C; Duftner, C; Schirmer, M, 2007) |
| "An open, multi-centre trial was carried out to assess the efficacy and tolerance of acemetacin in the treatment of patients suffering from various rheumatic diseases." | 5.05 | Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial. ( Rechziegler, H; Zündorf, P, 1985) |
| "This research aimed to develop patches for transdermal delivery of acemetacin, which can be used to treat rheumatic diseasesand to determine their potential use." | 4.12 | Preparation and ( Aksu, NB; Husseın, HA; Okur, ME; Özcan Bülbül, E; Üstündağ Okur, N; Yeğen, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özcan Bülbül, E | 1 |
| Husseın, HA | 1 |
| Yeğen, G | 1 |
| Okur, ME | 1 |
| Üstündağ Okur, N | 1 |
| Aksu, NB | 1 |
| Bori Segura, G | 1 |
| Torres y Gutierrez Rubio, A | 1 |
| Herrera Gómez, LE | 1 |
| Olguín Uribe, J | 1 |
| Dejaco, C | 1 |
| Duftner, C | 1 |
| Schirmer, M | 1 |
| Rechziegler, H | 2 |
| Thebud-Lassak, R | 1 |
| Zündorf, P | 1 |
1 review available for acemetacin and Rheumatic Diseases
| Article | Year |
|---|---|
[Clinical profile of acemetacin].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Humans; Indomethacin; Rand | 1990 |
4 trials available for acemetacin and Rheumatic Diseases
| Article | Year |
|---|---|
Efficacy and tolerability of acemetacin, a non-steroidal anti-inflammatory drug, in Mexican patients: result of the ETAPAM Study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Athletic Injuries; Female; Humans; Indomethaci | 2002 |
Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Dose-Response Relationship, D | 2007 |
[Clinical profile of acemetacin].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Humans; Indomethacin; Rand | 1990 |
Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Clinical Tri | 1985 |
1 other study available for acemetacin and Rheumatic Diseases
| Article | Year |
|---|---|
Preparation and
Topics: Administration, Cutaneous; Humans; Rheumatic Diseases; Skin; Transdermal Patch | 2022 |